Tinnitech International is an innovative Italian start-up founded by a group of high-profile investors and managers who have developed the first ‘synchronous multimodal therapy’ to treat tinnitus with a versatile, effective and long-lasting method.
About Us
Development
Innovative medical device with 3 active elements for the treatment of tinnitus.
Security
Accuracy and effectiveness of specific electromagnetic fields, applied to the auditory organ in a regime of proven harmlessness.
Results
Progressive reduction in the intensity of the symptoms perceived, and progressive increase in the duration of relief obtained with Aqufree.
Acufree
The non-invasive and customisable remedy that works by reducing the effects of tinnitus. Acufree, unlike the onerous current treatments that do not achieve a prolonged reduction of the disorder, obtains a progressive and lasting remedy to tinnitus disorders. Tinnitus is an auditory disorder consisting of noises (whistling, buzzing, rustling, pulsations, etc.) that occur with different intensities and tend to intensify over time, until they become chronic, affecting the quality of life.
Acufree has demonstrated in certified clinical trials that it is able to improve the results obtained so far in the battle against tinnitus, achieving a reduction in symptoms and a prolongation of the beneficial effects even after 1 year.
Hence the claim to be a ‘progressive and lasting remedy to tinnitus disorders’.
Learn more
The Situation
Tinnitus: Every day in the world, millions of people suffer a loss of quality of life due to this complex disease, of multiple and partially unknown origins, and which has hitherto been incurable.
The global total is around 750 Million NB. Data not including occasional tinnitus phenomena).
Europe
78
million / 764 million
Australia
5
million / 25 million
Latin America
178
million / 642 million
Africa
89
million / 1.2 billion
U.S.A.
39
million / 329 million
China
146
million / 1.4 billion
Asia
177
million / 4.5 billion
India
38
million / 1.3 billion
Intellectual property
The technology developed by our company is supported by a ‘portfolio of intellectual property’. Tinnitech INT has a policy of extensive patent coverage of its research, technology and product.
State of the art
Tinnitech INT’s innovative Anti-ACUFENI treatment uses cutting-edge electronics that, through the integration of auditory, inductive and capacitive instruments, triggering beneficial effects, both physiological and psycho-perceptual.
The combined delivery of these active elements develops an effective synchronous multimodal therapy.
Expert consultations:
Every Tuesday from 3 p.m. to 7 p.m.
For information on the operation of ACUFREE or treatment features.
call the 3398105551
Head Office
Tecnopolo Romano – c/o Incubatore Innova
Via G. Peroni 386 – 00131 Rome
North Italy Headquarters
c/o Ecupharma SRL
Via Newton 9a – 20016 Pero, Milan
Direct telephone line
+39 3355273686
Administration
06/ 40040358
